Press Releases

Press releases for:
July 2, 2008 DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group
June 26, 2008 DiagnoCure appoints Vice President, Marketing and National Sales
June 13, 2008 DiagnoCure announces second quarter 2008 results
June 5, 2008 DiagnoCure to host Q2 2008 earnings conference call and webcast
June 3, 2008 DiagnoCure's molecular diagnostic tests - PCA3 and GCC - discussed at scientific meetings
May 20, 2008 DiagnoCure reports key milestones in the commercialization of its molecular diagnostic tests
May 1, 2008 DiagnoCure to present at two conferences
April 1, 2008 DiagnoCure provides update on operations
March 19, 2008 New study supports use of PCA3-based test for prostate cancer diagnosis
March 5, 2008 DiagnoCure announces first quarter 2008 results
February 25, 2008 DiagnoCure announces Q1 2008 earnings conference call
January 29, 2008 DiagnoCure appoints Chief financial officer
January 24, 2008 DiagnoCure previews Previstage GCC to key audiences

STOCK INFORMATION

Symbol TSX: CUR
Last trade 2.95
Open 2.96
Net change -0.04
High 2.96
Low 2.95
52 week range 1.67 - 3.09
Volume 4,900
As of 2008-07-25
13:46 EST
$CAN. Quotes are delayed.
For information purposes only.

Quick Facts—April 30, 2008

Year-end October 31
Shares Outstanding 41.8 million
Market Capitalization $84.5 million

Documents to Download

PDF Corporate Brochure
PDF Corporate Fact Sheet
PDF Second quarter
PDF 2007 Annual Report

Latest News

Stay Informed

Subscribe to e-mail news alerts